Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1470071
European Journal of Endocrinology, Vol 147, Issue 1, 71-75
Copyright © 2002 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katsuki, A
Right arrow Articles by Adachi, Y
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katsuki, A
Right arrow Articles by Adachi, Y

Articles

Acute hyperinsulinemia is associated with increased circulating levels of adrenomedullin in patients with type 2 diabetes mellitus

A Katsuki, Y Sumida, EC Gabazza, S Murashima, H Urakawa, K Morioka, N Kitagawa, T Tanaka, R Araki-Sasaki, Y Hori, K Nakatani, Y Yano, and Y Adachi

Third Department of Internal Medicine, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan. katuki-a@clin.medic.mie-u.ac.jp

OBJECTIVE: To investigate the effect of acute hyperinsulinemia on the plasma levels of adrenomedullin (AM) in patients with type 2 diabetes mellitus. DESIGN: We measured the plasma levels of AM in 18 patients with type 2 diabetes mellitus and in 19 normal subjects before and during a euglycemic hyperinsulinemic clamp study (the goal was for blood sugar levels of 5.24 mmol/l and insulin levels of 1200 pmol/l). Both plasma AM and serum insulin were measured by immunoradiometric assays. RESULTS: Before the glucose clamp study there was no significant difference in the plasma levels of AM between patients with type 2 diabetes mellitus and normal subjects. During the glucose clamp study, the serum levels of insulin significantly increased (from 33.0+/-3.6 to 1344.6+/-67.8 pmol/ml, P<0.001), as did the plasma levels of AM (from 12.8+/-0.7 to 14.2+/-0.9 fmol/ml, P<0.03) only in patients with type 2 diabetes mellitus. There was a significant correlation between the change in circulating levels of insulin and AM (r=0.755, P<0.01). CONCLUSIONS: Acute hyperinsulinemia induced a significant increase in the plasma levels of AM in patients with type 2 diabetes mellitus. Increased insulin may regulate circulating levels of AM in patients with type 2 diabetes mellitus.


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
O Paulmyer-Lacroix, R Desbriere, M Poggi, V Achard, M-C Alessi, F Boudouresque, L. Ouafik, V Vuaroqueaux, M Labuhn, A Dutourand, et al.
Expression of adrenomedullin in adipose tissue of lean and obese women.
Eur. J. Endocrinol., July 1, 2006; 155(1): 177 - 185.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
M. Suematsu, A. Katsuki, Y. Sumida, E. C Gabazza, S. Murashima, K. Matsumoto, N. Kitagawa, H. Akatsuka, Y. Hori, K. Nakatani, et al.
Decreased circulating levels of active ghrelin are associated with increased oxidative stress in obese subjects
Eur. J. Endocrinol., September 1, 2005; 153(3): 403 - 407.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. M. White, P. E. Constantin, and W. C. Claycomb
Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function
Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H823 - H829.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Katsuki, Y. Sumida, H. Urakawa, E. C. Gabazza, N. Maruyama, K. Morioka, N. Kitagawa, Y. Hori, K. Nakatani, Y. Yano, et al.
Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type 2 Diabetes
Diabetes Care, May 1, 2003; 26(5): 1642 - 1643.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 European Society of Endocrinology.